Researchers have developed a novel diagnostic method using DNA methylation biomarkers from bilateral nasal swabs to detect nasopharyngeal carcinoma (NPC) noninvasively. Automated processing and epigenetic analysis enable early cancer screening with greater convenience and accuracy. This approach, published in BMC Cancer, could transform NPC detection and improve patient outcomes by facilitating timely intervention.